Precision Business Insights has published a report on the global idiopathic pulmonary fibrosis market, estimating its value at USD 4,596.0 Million in 2024 and is expected to expand at a compound annual growth rate (CAGR) of 7.2% over the forecast period 2025-2031. The report explores the market growth and potential opportunities in the market industry. Additionally, it offers a detailed analysis of how these elements will affect market demand dynamics and market performance throughout the forecast period.
View the detailed report description here - https://www.precisionbusinessinsights.com/market-reports/idiopathic-pulmonary-fibrosis-market
The Idiopathic Pulmonary Fibrosis (IPF) market is a global industry that develops, manufactures, and commercializes therapies, diagnostics, and supportive care solutions for idiopathic pulmonary fibrosis, a chronic and progressive lung disease characterized by lung tissue scarring, decreased oxygen transfer, and declining respiratory function.
Drivers:
Increasing incidence of IPF, particularly in aging populations, drives demand for effective therapies.
Expanding research and clinical trials by pharmaceutical companies encourage new drug development.
The global idiopathic pulmonary fibrosis market segmentation:
1) By Molecule: nintedanib, Pirfenidone, and Other Drug Types
2) By Mode of Action: antifibrotic Agents, Tyrosine Kinase Inhibitors, and Other Modes of Action
3) By End User: hospitals and Clinics, Pharmacies, and Other End Users
Request sample report at https://www.precisionbusinessinsights.com/request-sample/?product_id=537590
Regional Overview:
The report also examines the current concerns and their Future Effects on the idiopathic pulmonary fibrosis market by the region. The report covers all regions and countries, North America was the largest and Asia was the fastest-growing region in the idiopathic pulmonary fibrosis market. The market has been segmented into numerous primary regions and a detailed evaluation of primary countries.
North America (U.S., Canada)
Europe (Germany, U.K., France, Italy, Russia, Spain, Rest of Europe)
Asia-Pacific (China, India, Japan, Australia, Southeast Asia, Rest of Asia Pacific)
Latin America (Mexico, Brazil, Argentina, Columbia, Rest of Latin America)
Middle East & Africa (GCC, Egypt, Nigeria, South Africa, Rest of Middle East and Africa)
The competitive landscape is dominated by major players like United Therapeutics Corporation, Boehringer Ingelheim International GmbH, Bristol-Myers Squibb Company, Cipla Inc., Hoffmann-La Roche Ltd, FibroGen Inc., MediciNova Inc., Jubliant Pharma Limited (Jubliant Cadista Limited), Merck & Co. Inc., Horizon Therapeutics Inc., Avalyn Pharma Inc., CS Pharmaceuticals
About Precision Business Insights:
We are a market research company that strives to provide the highest quality market research insights. Our diverse market research experts are enthusiastic about market research and therefore produce high-quality research reports. We have over 500 clients with whom we have a good business partnership and capacity to provide in-depth research analysis for more than 30 countries. In addition to deliver more than 150 custom solutions, we already have accounts with the top five medical device manufacturers.
Precision Business Insights offers a variety of cost-effective and customized research services to meet research requirements. We are a leading research service provider because of our extensive database built by our experts and the services we provide.
Contact:
Mr. Satya
Precision Business Insights | Toll Free: +1 866 598 1553
Email: sales@precisionbusinessinsights.com
Kemp House, 152 – 160 City Road, London EC1V 2NX
Web: https://precisionbusinessinsights.com/ | D U N S® Number: 852781747
- bomma's blog
- Log in or register to post comments